edoc

Items where Author is "Grishina, Olga"

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item Type | Refereed
Jump to: 2016 | 2011 | 2009
Number of items: 3.

2016

Schorb, Elisabeth and Finke, Juergen and Ferreri, Andrés J. M. and Ihorst, Gabriele and Mikesch, Kristina and Kasenda, Benjamin and Fritsch, Kristina and Fricker, Heidi and Burger, Elvira and Grishina, Olga and Valk, Elke and Zucca, Emanuele and Illerhaus, Gerald. (2016) High-dose chemotherapy and autologous stem cell transplant compared with conventional chemotherapy for consolidation in newly diagnosed primary CNS lymphoma--a randomized phase III trial (MATRix). BMC Cancer, 16. p. 282.

2011

Socié, Gérard and Schmoor, Claudia and Bethge, Wolfgang A. and Ottinger, Hellmut D. and Stelljes, Matthias and Zander, Axel R. and Volin, Liisa and Ruutu, Tapani and Heim, Dominik A. and Schwerdtfeger, Rainer and Kolbe, Karin and Mayer, Jiri and Maertens, Johan A. and Linkesch, Werner and Holler, Ernst and Koza, Vladimir and Bornhäuser, Martin and Einsele, Hermann and Kolb, Hans-Jochem and Bertz, Hartmut and Egger, Matthias and Grishina, Olga and Finke, Jürgen and ATG-Fresenius Trial Group, . (2011) Chronic graft-versus-host disease : long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti-T-cell globulin ATG-Fresenius. Blood, Vol. 117, H. 23. pp. 6375-6382.

2009

Finke, Jürgen and Bethge, Wolfgang A. and Schmoor, Claudia and Ottinger, Hellmut D. and Stelljes, Matthias and Zander, Axel R. and Volin, Liisa and Ruutu, Tapani and Heim, Dominik A. and Schwerdtfeger, Rainer and Kolbe, Karin and Mayer, Jiri and Maertens, Johan A. and Linkesch, Werner and Holler, Ernst and Koza, Vladimir and Bornhäuser, Martin and Einsele, Hermann and Kolb, Hans-Jochem and Bertz, Hartmut and Egger, Matthias and Grishina, Olga and Socié, Gérard. (2009) Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors : a randomised, open-label, multicentre phase 3 trial. The Lancet oncology, Vol. 10. pp. 855-864.

This list was generated on Thu Mar 28 11:57:58 2024 CET.